---
schema_version: "secwatch.filing_event.v1"
accession: "0001516551-23-000034"
form_type: "8-K/A"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2023-03-27T23:59:59+00:00"
generated_at: "2026-06-17T14:47:33.755354+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Skye Bioscience appoints Director Deborah Charych to Nominating and Corporate Governance Committee

## Summary
- On March 21, 2023, Board appointed Dr. Deborah Charych to the Nominating and Corporate Governance Committee, effective immediately.
- Amendment to Feb 16, 2023 8-K that reported Dr. Charych's appointment as director.
- No other changes to committee assignments or board composition.

## SEC filing metadata
- accession: 0001516551-23-000034
- form_type: 8-K/A
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2023-03-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000151655123000034/0001516551-23-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000151655123000034/skye-20230214.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001516551-23-000034
- JSON: https://secwatch.observer/filing/0001516551-23-000034.json
- Plain text: https://secwatch.observer/filing/0001516551-23-000034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.